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Abstract
Molecular imaging techniques as well as nanoparticle applicable to molecular imaging 
are being explored to improve the cancer detection accuracy, which help to manage effi-
ciently at the early stage. Among the various imaging technologies, optical imaging is a 
highly sensitive detection technique that allows direct observation of specific molecular 
events, biological pathways, and disease processes in real time through imaging probes 
that emit light in a range of wavelengths. Recently, nanoparticles have provided signifi-
cant progresses that can be simultaneously used for cancer diagnosis and therapy (cancer 
theranostics). Theranostics aims to provide “image-guided cancer therapy,” by integrat-
ing therapeutic and imaging agents in a single platform. In addition, molecular imaging 
techniques facilitate “image-guided surgery” enabling maximization of tumor excision 
and minimization of side effects. The optical signals generated by fluorescence nanopar-
ticles offer the possibility to distinguish tumor sites and normal tissues during surgery by 
real-time guidance, thereby increasing the long-term patient survival. These techniques 
will considerably contribute to reducing cancer recurrence and developing more effective 
cures. In this chapter, we will introduce diverse research on nanomaterials-based optical 
imaging for effective cancer therapy.
Keywords: molecular imaging, optical imaging, nanoprobe, cancer diagnosis,  
imaging-guided therapy, imaging-guided surgery
1. Introduction
Cancer is one of the leading causes of death. So many researchers have made great efforts to 
improve cancer management [1]. An early cancer diagnosis provides the most efficient and 
effective management of cancer treatment with the use of surgical methods or chemothera-
peutic agents. Therefore, techniques for detecting cancer at early stages have been developed 
to improve the detection accuracy. Molecular imaging techniques have undergone explosive 
growth over the past several decades and are important tools for cancer diagnosis and prognosis 
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in the clinic; they include positron emission tomography (PET), computed tomography (CT), 
magnetic resonance (MR) imaging, and optical imaging [2–4]. Molecular imaging techniques 
can identify the cancer mass on the basis of its physical properties, which may have major 
benefits for personalized diagnosis and for the prediction and monitoring of the response to 
therapy. Many researchers have made efforts to develop diverse imaging probes or contrast 
agents, thereby enabling the visualization of cellular function and the characterization and 
measurement of molecular processes in living organisms at the cellular and molecular lev-
els without perturbing them. Such tools can help obtain more accurate information about 
early-stage cancer using molecular imaging [4]. Among the molecular imaging tools, optical 
imaging, which includes fluorescence and bioluminescent imaging, can provide particularly 
highly sensitive detection by using the various wavelengths emitted by fluorescent nanopar-
ticles. In the UV and visible regions, light does not deeply penetrate into tissues, because it is 
easily absorbed and scattered by endogenous biomolecules (e.g., water and hemoglobin), and 
tissues generate strong auto-fluorescence [4]. However, light in the near-infrared (NIR) region 
(~650–900 nm) is minimally absorbed in living tissues and can penetrate more deeply, to a 
depth of several centimeters, with high signal-to-noise ratios (SNRs) [2]. The development of 
specific, sensitive, and targeted imaging probes is required for the success of optical imaging 
techniques in cancer diagnosis. Recently, nanomaterial-based optical imaging probes have 
been used extensively to non-invasively monitor the target biomolecules or biological path-
ways for cancer diagnosis and therapy compared with single molecule-based imaging agents. 
Fluorescent proteins and organic dyes are conventionally used to label cells and subcellu-
lar targets due to their small size, good biocompatibility, and water dispersibility. However, 
fluorescent nanomaterials such as quantum dots (QDs), gold nanoparticles, up-conversion 
nanocrystals, and silicon nanoparticles have shown several distinct advantages compared 
to fluorescent proteins and organic dyes [5–9]. These advantages include high resistance to 
photobleaching (photostability) and high quantum yields (QY), thus enabling the acquisition 
of optimal information of biological interest with high sensitivity in both in vitro and in vivo 
models [9]. In addition, nanomaterials (or nanoparticles) have the advantage that they can be 
easily modified with different molecules and delivered to the tumor along blood vessels with 
Figure 1. Schematic illustration of a multifunctional nanocomposite. Reproduced from Ref. [12] with permission of ACS 
Publications.
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immune systems [10–13]. In this chapter, we explain the benefits of optical imaging and the 
importance of nanomaterial-based imaging agents for effective cancer therapy. We will focus 
on research on using nanomaterials as optical imaging agents and their diverse applications 
(Figure 1).
2. Passive and active targeting for cancer imaging
2.1. Passive targeting
Various nanoparticle systems are being explored for their potential use in bioimaging for 
cancer diagnosis or treatment because of their unique properties, including their large sur-
face-to-volume ratio, high biocompatibility, facile surface modification, and overall structural 
robustness. In addition, they have unique optical, magnetic, and electron properties, which 
make them ideal candidates for signal generation and transduction in the development of 
sensing systems [5–8, 12, 14–20]. Moreover, some nano-sized materials exhibit unique physi-
cal properties, such as a proper size, surface charge, stability, shape, and hydrophilicity, which 
can aid their effective delivery to the desired site. The delivery of nano-sized agents is affected 
by the enhanced permeability and retention (EPR) effect, which is a unique property of solid 
tumors that is related to their anatomical and pathological differences from normal tissues. 
Unlike normal tissues, when tumor tissue produces neovascularization, it contains a discon-
tinuous or absent basement membrane, making it “leaky.” Therefore, the pore sizes of the 
blood vessels in most peripheral human tumors are hundreds of nanometers in diameter. This 
EPR effect leads to the passive accumulation of large molecules and small particles in tumor 
tissues due to the cut-off size of the leaky vasculature and retention with long circulation 
times, which is called passive targeting [21–26]. For successful bioimaging via passive target-
ing, both a size ranging from 100 to 200 nm in diameter and a prolonged circulation half-life 
in the blood with biocompatibility are required. Hydrophilic materials such as poly(ethylene 
glycol) (PEG) have been extensively investigated as effective ways to provide hydrophilic 
“stealth” properties, resulting in both the inhibition of plasma protein (opsonin) absorption 
and decreased recognition by the mononuclear phagocytic system (MPS) in the reticuloen-
dothelial system (RES), such as the liver and spleen, thus producing longer circulation times 
(Figure 2) [27–29].
In addition, positively charged (cationic) nanoparticles can easily enhance endocytosis or 
phagocytosis for cell labeling via electrostatic interactions with the negatively charged cellu-
lar membrane. Among bio-imaging techniques, well-tailored superparamagnetic nanocrystals 
are of great interest for cancer detection via magnetic resonance (MR) imaging due to their 
high sensitivity and specificity due to the nanoeffect. Lim et al. [30–32] reported the success-
ful fabrication of various types of water-soluble PEGylated magnetic complexes for magne-
tism-related biomedical applications and demonstrated their potential as highly efficient MRI 
imaging agents. Fluorescence and optical imaging techniques are important tools for in vivo 
and cellular imaging, and they can provide vital information for cancer diagnosis and therapy 
in its early stages. In particular, for the fluorescence wavelength, near-infrared (NIR) light is 
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preferred for tissue and in vivo imaging compared to visible light because of its minimal dam-
age to the tissue, which allows deep tissue penetration, and low auto-fluorescence interference 
due to the reduced scattering of long wavelength photons [9].
2.2. Active targeting
Active targeting, is also called as ligand-mediated targeting, involves utilizing targeting moi-
eties that are anchored on the surface of nanoparticles and form strong interactions with a 
particular cell surface marker (e.g., EGFR, HER2/neu, transferrin, CD44) of the target cancer 
(Figure 3) [33, 34].
Targeting moieties, such as antibodies, peptides (Arg-Glyc-Asp (RGD)), nucleic acids (aptam-
ers), and polysaccharides (hyaluronan, dextran), lead to enhanced selective delivery and 
uptake in the target cells, tissues, organs, or subcellular domains and minimize uptake by 
the RES system [34–53]. Active tumor targeting is more efficient and specific than passive 
targeting, and can facilitate early cancer detection. In particular, active tumor-targeted imag-
ing can quantify the target expression through molecular imaging, so it is an indispensable 
tool in diagnosis and disease management. For example, for the selective detection of tumors 
expressing a high level of epidermal growth factor receptors (EGFR), anti-EGFR antibody-
modified nanoparticles are widely used as imaging agents for MR, CT, and optical imag-
ing. CD44 is a cell surface glycoprotein that is overexpressed in breast cancer and gastric 
cancer stem cells and is associated with cancer growth, migration, invasion, and angiogen-
esis. Hyaluronan (HA), which is an immune–neutral polysaccharide, forms a specific interac-
tion with CD44. Lim et al. [50, 51] developed a hyaluronan-modified magnetic nanoprobe 
for detecting CD44-overexpressing breast cancer via MR imaging, which showed superior 
targeting efficiency with MR sensitivity in in vitro and in vivo studies. Angiogenesis appears 
to be one of the most crucial steps in tumor translation to the metastatic form, in which it is 
Figure 2. Main advantages of the PEGylated proteins. PEG is a shielding the protein surface from degradation agents by 
steric hindrance. Moreover, the increased size of the conjugate decreases the kidney clearance of the PEGylated protein. 
Reproduced from Ref. [27] with permission of Elsevier.
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capable of spreading to other parts of the body by degrading the basement membrane and 
forming a new vascular structure. During angiogenesis, a variety of proangiogenic factors is 
secreted by tumor cells, including vascular endothelial growth factor (VEGF), platelet-derived 
growth factor (PDGF), basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), and integrin 
α
v
β
3
. Targeted-molecular imaging of vascular or angiogenesis can provide accurate anatomic 
details for effective cancer management. Aptamers (Apt) are short nucleic acid molecules that 
can bind to target antigens with high affinity and specificity. To understand neovasculariza-
tion and angiogenesis in cancer, Aptαvβ3-conjugated magnetic nanoparticles (Aptαvβ3-MNPs) 
have been developed to enable the precise detection of integrin-expressing cancer cells using 
MRI imaging. This work demonstrated that Aptαvβ3-MNPs have the potential to be used for 
accurate tumor diagnosis [52]. In addition, vascular endothelial growth factor (VEGF121)/
rGel modified MRI imaging agents were developed to obtain sensitive angiogenesis imaging 
of orthotopic bladder tumors that showed the development of a clear neoangiogenic vascular 
distribution [53]. The tumor microenvironment plays a critical role in tumor initiation, pro-
gression, metastasis, and resistance to therapy [54–61]. The microenvironment differs from 
that of normal tissues because of the dynamic network within normal tissues, including blood 
and lymphatic vessels, extracellular matrix proteins, and both enzyme and immune compo-
nents. These unique characteristics lead to a matrix remodeling (e.g., up-regulation of matrix 
proteins and activation of specific proteases), a deficiency of oxygen and other nutrients, a 
decreased pH (low pH), hypoxia and increased amounts of reactive oxygen species (ROS) [57]. 
The changes in the physiological characteristics of tumor microenvironments are consistent, 
regardless of the type of cancer, so it is possible to use these as a universal indicator for cancer 
detection. Vesicular pH plays a pivotal role in cell metabolism processes, such as proliferation 
and apoptosis. Choi et al. [58] developed a colorimetric redox-polyaniline nanoindicator to 
simply detect and quantify a broader biogenic pH range with superior sensitivity by employ-
ing one-dimensional turn-on of the FRET signal (Figure 4). They fabricated polyaniline-based 
Figure 3. A schematic illustration showing methods used for active targeting of nanoparticles. (A) Antibody-based 
targeting, (B) Aptamer-based targeting, and (C) Ligand-based targeting of nanoparticels. Reproduced from Ref. [34] with 
permission of Springer.
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nanoprobes that exhibited convertible transition states according to the proton concentration 
as an in situ indicator of the vesicular transport pH [58].
The tumor pH is usually more acidic than that of normal tissues due to increased aerobic 
glycolysis, which is called the Warburg effect (tumor have a pH of 6.2–6.9, and normal tissues 
have a pH of 7.4) [62, 63]. This can promote tumor metastasis by generating an invasive envi-
ronment for tearing down the extracellular matrix and for tissue remodeling. Many studies 
have reported signal “off–on” imaging agents activated by pH, such as fluorescence probes 
and MRI contrast agents that target the acidic pH conditions of tumors for tumor imaging 
[12, 13, 59]. Kim et al. [59] have developed a pH-responsive T1 (which is the recovery of 
magnetization along the longitudinal axis) contrast agent for MR imaging. Core–shell MnO@
Mn
3
O
4
 urchin-shaped nanoparticles are synthesized via an anisotropic etching process. The 
manganese ions released from the MnO phase in the low-pH sites within tumor cells lead 
to an enhanced T1 contrast image for the entire tumor mass. In addition, specific stromal 
cell-derived proteases, such as matrix metalloproteases (MMP), matrix cysteine cathepsins, 
and serine proteases, are overexpressed in primary tumors. These proteases induce the epi-
thelial-to-mesenchymal transition (EMT) and promote invasion and metastasis by degrading 
the extracellular membrane. Molecular imaging of the activity of proteases has the potential 
to determine tumor malignancy, guide the development of diagnostic tools, and evaluate 
the efficacy of treatment (Figure 5(A)) [60]. MMPs are the most prominent family of pro-
teases associated with tumorigenesis. Their expression and activity are highly enhanced in 
many types of human cancer and are strongly implicated in advanced cancer states. Tumor 
microenvironment-targeted molecular imaging has the potential to provide clinically signifi-
cant progress. Emerging evidence suggests that microRNAs can also function as a diagnostic 
biomarker for human cancers because they can act as tumor suppressor genes or oncogenes. 
Imaging the intracellular distribution of specific miRNAs should provide insight into 
the mechanisms of metastasis and invasion. Kim et al. [61] reported smart nanoprobes, 
Figure 4. (A) Schematic illustration of organic nanoindicator based on polyaniline nanoparticle for the detection of 
endolysosomal compartments. Synthesis steps of nanoindicator based on polyaniline in mesosilica template when 
using heterometal nanoparticle (IsNP) as oxidant. Emission of FPSNICy7 appears at endosomes. While migrating from 
endosomes to lysosomes, transition state of polyaniline transferred to emeraldine salt state due to the increment of 
proton concentration. The emission of FPSNICy3 gradually appears at lysosomes. (B) Redox switching property and 
sensitivity of PSNI from pH 3.95 to 7.23. Reproduced from Ref. [58] with permission of Springer.
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i.e., hyaluronic acid (HA)-based nanocontainers containing miRNA-34a beacons (bHNCs), 
for the intracellular recognition of miRNA-34a levels in metastatic breast cancer cells. They 
confirmed the microRNA-34a expression levels through in vitro and in vivo optical imaging 
using bHNCs (Figure 5(B)) [61].
3. Multimodal imaging for cancer imaging
Current imaging techniques play an important role in enabling the early detection of several 
diseases, including cancer, due to their ability to locate tumors and assess the tumor activ-
ity. The characteristics of various imaging modalities are briefly summarized (Table 1) [7, 
64]. However, these techniques are insufficient to provide reliable and accurate information 
at the disease site, due to their low sensitivity or limits in their spatial resolution (Table 1).
Computed tomography (CT) is useful for tumor staging but offers poor soft tissue contrast, 
with resulting poor sensitivity and specificity in screening. Magnetic resonance imaging 
(MRI) offers excellent contrast without ionizing radiation but has temporal and financial 
needs that are likely inconsistent with high-throughput screening. Positron emission tomog-
raphy (PET), which has very high sensitivity, can investigate various molecular and bio-
chemical properties but is more suitable for monitoring the response to therapy than for 
detecting early lesions due to its limited spatial resolution. Therefore, multimodal imaging, 
i.e., the integration of two or more imaging techniques in a single examination, should offer 
the synergistic advantages of each to provide accurate information for tumor diagnosis such 
as high spatial resolution, soft tissue contrast, and biological information on the molecular 
level with high sensitivity [46, 65–73]. Recently, various types of hybrid nanoparticles have 
Figure 5. (A) Schematic illustration of the dual imaging process of anchored proteinase-targetable optomagentic 
nanoprobes  with activatable fluorogenic peptides (MNC-ActFP). Reproduced from Ref. [60] with permission of Wiley-
VCH. (B)  Schematic illustration of miR-34a beacon delivery system for targeted intracellular recognition of miR-34a 
based on Hyaluronic acid (HA)-coated nanocontainers that encapsulate the miR-34a beacons (bHNCs). Reproduced 
from Ref. [61] with permission of ACS Publications.
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been used for multimodal imaging by combining the strengths of individual components 
into single nano-structured systems. Multimodal imaging probes enable both magnetic 
and optical imaging to provide great benefits for in vivo disease diagnosis and the in situ 
monitoring of living cells. In addition, it is reported that MR/CT multimodal nanoprobes 
can provide complementary information for tumor-associated blood vessels and the tumor 
microenvironment [71]. Uniformly sized tantalum oxide nanoparticles were synthesized 
using a microemulsion method and were modified using various silane derivatives, such 
as polyethylene glycol (PEG) and fluorescent dye molecules, through simple in situ sol-gel 
reaction. These nanoparticles exhibited remarkable performances in in vivo simultaneous 
fluorescence imaging as well as X-ray CT angiography and bimodal image-guided lymph 
node mapping [72].
Lim et al. [73] developed fluorescent magnetic nanoprobes to acquire biological information 
at different object levels, i.e., in vivo detection and ex vivo validation, for characterizing tumor 
angiogenesis, in which magnetic nanocrystals are encapsulated by the fluorescent amphi-
philic polymer (Figure 6). Additionally, targeted multimodal imaging systems by modify-
ing targeting moieties to increase the selective accumulation at the disease site has shown 
promising results. In this case, several factors should be considered, including the appro-
priate choice of a targeting moiety and its conjugation method. Yang et al. [49] developed 
Modality Energy source Depth Temporal 
resolution
Advantage Disadvantage
Optical 
imaging
Visible light or 
near-infrared
<1 cm Seconds to 
minutes
Noninvasiveness, 
no harmful effect by 
nonionizing radiation
Relatively low spatial 
resolution
MR imaging Radiofrequency 
magnetic field
No limit Minutes to 
hours
Noninvasiveness, high 
spatial resolution
Relative low 
sensitivity, long scan 
and post-processing 
time, mass quantity of 
probe may be needed
PET imaging High-energy γ rays No limit 10 s to 
minutes
Noninvasiveness, high 
sensitivity
Exposure to ionizing 
radiation, relatively 
low spatial resolution
Ultrasound 
imaging
High-frequency 
sound
mm to 
cm
Second to 
minutes
Noninvasiveness, real 
time, low cost, no harmful 
effects by nonionizing 
radiation
Limited spatial 
resolution, unsuitable 
for examination of 
digestive organs and 
bone
CT imaging X-ray No limit Minutes Noninvasiveness, high 
contrast resolution
Relatively high dose 
of ionizing radiation, 
limited soft tissue 
resolution, exposure 
to ionizing radiation
Reproduced from Ref. [12] with permission of ACS Publications.
Table 1. Characteristics of imaging modalities.
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Cetuximab-conjugated fluorescent magnetic nanohybrids (CET-FMNHs) that served as effec-
tive agents for both magnetic resonance (MR) and fluorescence optical imaging of human 
epithelial cancer.
4. Optical-imaging-based cancer therapy
4.1. Optical imaging in drug delivery (Theranostics)
Recently, nanoparticles have provided significant progress in cancer theranostics due to their 
unique physicochemical properties, in which both diagnosis and therapeutic functions can be 
achieved simultaneously. Theranostics aims to provide image-guided cancer therapy by inte-
grating imaging and therapy, which are particularly interesting fields in Nanomedicine [12]. 
Theranostic nanoparticles comprise at least three components: (i) the biological payload, (ii) 
the carrier, and (iii) surface modifiers (Figure 1) [74–93]. Biological payloads include imaging 
agents and therapeutic agents. Therefore, they can allow the simultaneous delivery of thera-
peutic agents to the tumor site and real-time tracking of their biodistribution in vivo. Optical 
imaging has advantages in theranostics because it allows the non-invasive monitoring of the 
progression of diseases and therapy [84]. For example, Misra et al. [85] synthesized blue-light-
emitting ZnO quantum dots combined with biodegradable chitosan (N-acetylglucosamine) 
for tumor-targeted drug delivery (a ZnO-QD-chitosan-folate carrier), which was loaded 
with an anti-cancer drug (DOX). The DOX-loaded ZnO-QD-chitosan-folate carrier exhibited 
highly stable QDs because of its hydrophilicity and the cationic charge of chitosan as well as 
a rapid drug release profile with a controlled release.
Ryu et al. [86–89] developed chitosan-based nanoparticles (CNPs) that were labeled with 
Cy 5.5 for optical imaging and encapsulated with paclitaxel (PTX) as an anticancer drug 
Figure 6. (A) Illustration of simultaneously self-assembled fluorescent magnetic nanoprobes (FMNPs) as multimodal 
biomedical imaging probes. (B) MR images of tumor-bearing mice after injection of the FMNPs (i: xenograft tumor 
model and ii: orthotopic bladder tumor model) and (C) fluorescence images of their excised tumor slides, respectively. 
Reproduced from Ref. [73] with permission of Elsevier.
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(PTX-Cy5.5-CNP) (Figure 7). They confirmed that the PTX-Cy5.5-CNP was effectively deliv-
ered to the tumor sites by optical imaging and that it showed enhanced therapeutic efficacy 
in tumor tissues while minimizing its toxicity to normal tissues. Smart theranostic nanosys-
tems that respond to environmental changes (e.g., pH) have been designed for controlled drug 
release, low drug loss and low side effects [90–92]. Wu et al. prepared nanogels via the in situ 
immobilization of CdSe quantum dots (QDs) in the interior of pH and temperature-responsive 
hydroxypropylcellulose-poly(acrylic acid) (HPC-PAA) semi-interpenetrating (semi-IPN) poly-
mer networks (HPC-PAA-CdSe hybrid nanogels). These nanogels demonstrated potential as 
excellent drug carriers, providing a high drug loading capacity for TMZ as a model antican-
cer drug and offering the possibility of pH-regulated drug delivery [93]. Jang et al. [94] used 
nanovesicles containing poly(L-lysine-graft-imidazole) (PLI)/miR complexes (NVs/miR) to 
systemically deliver miR-34a for CD44 expression-based cancer therapy (Figure 8).
In this system, the PLI acts to deliver miRNA to the site of action via the buffering effect of the 
imidazole residues under endosomal pH. This systemic delivery of miR-34a using our NVs 
shows the most favorable delivery efficiency, a significant suppression of CD44 expression, 
and increased apoptosis in the in vivo models [94]. In optical imaging, fluorophores, such as 
fluorescent dyes, bioluminescent proteins and fluorescent proteins, are widely used to moni-
tor molecular events. However, they are easily susceptible to photobleaching. Fluorescent 
nanoparticles (e.g., quantum dots, upconversion nanoparticles) were developed that com-
plement the weakness of fluorophores; however, they also exhibited potential toxicity [95]. 
Among various nanoparticles, gold nanoparticles are the most widely used in the biomedical 
field because of their advantageous properties such as biocompatibility and facile modifica-
tion [96–102]. According to their size, shape, and structure, they also have controllable sur-
face plasmon resonance (SPR). Among gold nanoparticles, rod-shaped gold nanoparticles 
Figure 7. Theragnostic chitosan-based nanoparticles (CNPs) for cancer imaging and chemotherapy. (A) Conceptual 
description of theragnostic nanoparticles labeled with Cy5.5 for imaging and encapsulated with PTX for cancer therapy 
(PTX–Cy5.5–CNP). (B) In vivo images of the tumor-bearing mice treated with PTX–Cy5.5–CNP of different drug 
concentrations (5, 10, and 20 mg/kg) every third day. Reproduced from Ref. [88] with permission of Elsevier.
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(gold nanorods) can be used as direct NIR absorption imaging probes because their main 
absorption band is located in the NIR region due to the longitudinal surface plasmon.
Choi et al. noted that cRGD-conjugated gold nanorods showed excellent tumor targeting 
ability via NIR absorption imaging with no cytotoxicity. Additionally, the nanorods showed 
sufficient cellular uptake in a glioblastoma in vivo model, thus demonstrating their potential 
as α
v
β
3
 integrin-targeted imaging probes [103, 104]. In particular, gold nanoparticles are use-
ful for image-guided thermal therapy (also called hyperthermia or photothermal therapy) 
because they can absorb laser irradiation and convert the energy into a heat source via elec-
tron excitation and relaxation. Hyperthermia can induce apoptotic cell death in tumor tissues 
via heat generation, which provides a less invasive and localized therapy for cancer. As a 
result, it has been used to improve therapeutic efficacy and survival rates in combination with 
radiotherapy or chemotherapy for tumors. Choi et al. [105, 106] also prepared Cetuximab 
(CET)-conjugated gold nanorods and evaluated their hyperthermal properties under NIR 
irradiation (Figure 9). Gold nanorods have been frequently used to trigger hyperthermia in 
combination with an NIR laser, which is more effective for tissue penetration than are UV 
and visible light. After NIR laser irradiation, CET-PGNRs showed strong therapeutic efficacy 
in tumor-bearing mice, thus demonstrating the potential of CET-PGNRs for simultaneous 
Figure 8. (A) Schematic illustration and characterization of nanovesicles containing PLI/miR complexes (NVs/miR) that 
proton buffering promoted by protonation of a pH-responsive cationic polymer, poly(L-lysine-graft-imidazole (PLI), 
at endosomal pH, (B) in vivo anti-tumor effects induced by NVs/miR-34a, (C) I optical images of Cy5.5-labeled NVs 
containing PLI/fluorescein-labeled miR (Cy5.5-NVs/FL-miR) in an MKN-74 gastric subcutaneous xenograft model after 
intravenous injection of Cy5.5-NVs/FL-miR at various time intervals (pre-injection, 0, 3, and 6 h) and (D) its photon 
counts from the tumor regions after injection of Cy5.5-NVs/FL-miR. (E) Ex vivo optical images of excised organs (liver, 
stomach, brain, lung, kidney, spleen, heart, and muscle) at 6 h after injection of Cy5.5-NVs/FL-miR. The intensity maps 
on the fluorescence images display normalized photon counts and (D) confocal microscopy images of tumor sections 
from mice treated with Cy5.5-NVs/FL-miR. Green, red, and blue represent FL from miR, Cy5.5 from NVs, and Hoechst 
33342 from nucleus, respectively. Reproduced from Ref. [94] with permission of Elsevier.
Recent Advances in Bioimaging for Cancer Research
http://dx.doi.org/10.5772/intechopen.72725
21
absorption imaging and photothermal ablation of epithelial cancer cells with excellent target-
ing ability. Additionally, Choi et al. demonstrated highly sensitive terahertz (THz) molecular 
imaging using same probe (CET-PGNR) in both in vitro and in vivo models, indicating that 
its high thermal sensitivity can help extend photonic-based photothermal molecular imaging 
and be used for monitoring drug delivery processes and for early cancer diagnosis [105, 106]. 
Nam et al. developed “smart” gold nanoparticles that enable aggregation in mild acidic intra-
cellular environments due to their hydrolysis-susceptible citraconic amide surface, which 
induces a shift in the absorption to longer wavelength, in the far-red and near-infrared (NIR) 
regions. This smart feature is useful for photothermal cancer therapy [107].
4.2. Optical imaging guided surgery
The primary goal of cancer surgery is to maximize the tumor excision and minimize the col-
lateral damage. Molecular imaging techniques are required to achieve these goals, leading to 
“image-guided surgery” [108–117]. Especially, optical imaging is the most suitable for image-
guided surgery (or targeted surgery) because fluorescence signals can provide real-time guid-
ance to differentiate positive tumor margins and local malignant masses from normal tissues 
during surgery, thereby increasing the long-term patient survival. Near-infrared (NIR) imaging 
has particular potential to remove all neoplastic tissue at the surgical site because it is possible to 
obtain a low background signal and perform non-invasive real-time monitoring. Image-guided 
surgery is suitable for tumors that are difficult to differentiate from adjacent normal tissues 
(such as breast cancers), tumors that are next to complex structures with crucial physiological 
functions (such as brain tumors), or tumors that have high local recurrence or positive margin 
rates. Suitable probes for image-guide surgery must specifically detect and target cancerous tis-
sues by showing maximum signal from the target and minimum signal from the background.
A natural fluorophore called protoporphyrin (PpIX) has been clinically used for image-guided 
surgical resection of brain tumors (glioblastomas), demonstrating that its fluorescence signals 
Figure 9. (A) Schematic illustration of CET-PGNRs as NIR absorption imaging and photothermal therapeutic agents 
for epithelial cancer. (B) Noninvasive NIR absorption in vivo images of tumor tissues for intravenous injected CET-
PGNRs or PGNRs (control); white-dotted circles indicate the tumor regions. (C) Silver staining eosin. Tumor region was 
characterized by extensive pyknosis (green arrows) and cell vacuolization (white arrows) only in mice treated with CET-
PGNRs after NIR laser irradiation. Reproduced from Ref. [12] with permission of ACS Publications.
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are highly specific to tumor cells. Lovell et al. [116] have developed hydrogels using cross-
linked porphyrin co-monomers as strong optical tracers (Figure 10(A)). In in vivo studies, these 
could be used for the non-invasive fluorescence monitoring of subcutaneously implanted 
hydrogels over 2 months, without adverse effects or behavior. In addition, it was possible to 
non-invasively visualize where the gel was located and whether hydrogel degradation or pho-
tobleaching occurred. After surgical resection, while no residual fluorescence was detected 
in the mouse, hydrogel fluorescence was definitely recognized in the removed gel [116]. Hill 
et al. [117] demonstrated hyaluronic acid (HLA)-derived nanoparticles containing an indocya-
nine green (ICG) as near-infrared dye (NanoICG) for well delivery to tumors (Figure 10(B)). 
NanoICG exhibited quenched fluorescence and could be activated by disassembly in a mixed 
solvent (DMSO:H
2
O = 50:50). Strong fluorescence enhancement of the NanoICG was observed 
in a breast tumor xenograft model. The NanoICG were more completely delivered to tumors 
compared to free ICG, with strong contrast enhancement in the tumor with a lower back-
ground signal in the surrounding tissue, thus demonstrating the potential of the NanoICG 
as a probe.
5. Conclusion
Optical imaging is a powerful tool that can provide the real-time and direct observation of spe-
cific molecular events, biological pathways, and disease processes. As described in this chap-
ter, design strategies for imaging probes are important for accurate imaging to enable effective 
cancer management both in vitro and in vivo. Nanomaterial-based imaging probes can obtain 
Figure 10. (A) Porphyrin-cross-linked hydrogels and noninvasive monitoring and image-guided surgical resection 
by using them. (i) Structures of mTCPP (green) and PEG diamine (red). (ii) Schematic of the hydrogel. (e), from left to 
right, (iii) fluorescence images of a mouse with the hydrogel implanted subcutaneously and monitored noninvasively. 
(iv) Screen captures from a fluorescence camera used to guide fluorescently the surgical removal of the hydrogel in real 
time. Fluorescence was readily apparent transdermally (T.D.) or through the open incision, as indicated. (B) Hydrophobic 
moieties conjugated to HLA drive self-assembly into nanoparticles that can entrap ICG. Indocyanine green-loaded 
nanoparticles for image-guided tumor surgery (i) hydrophobic moieties conjugated to HLA drive self-assembly into 
nanoparticles that can entrap ICG. (ii) Preoperative imaging and (iii) postoperative imaging of iRFP shows the location 
of MDA-MB-231 breast tumor xenograft. Red arrows indicated extracted tumors, where iRFP signal showed due to the 
presence of NanoICG. Reproduced from Refs. [116, 117] with permission of ACS Publications.
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simultaneous imaging of multiple targets with high sensitivity, multimodal imaging, and 
imaging-guided therapy (theranostics) in combination with therapeutic agents. In particular, 
due to the advantages of optical imaging, the surgeon can simultaneously perform surgery 
while identifying where the cancer is located (imaging-guided surgery). These techniques will 
greatly contribute in reducing cancer recurrence and developing more effective cures.
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